Effect of variant genotypes ofFcγRIIIA at V/F 158 on HHV-8 seropositivity during HIV infection
| FcγRIIIA genotype . | Number of patients (%) . | Evidence for association, P values at . | ||
|---|---|---|---|---|
| HHV-8 positive . | HHV-8 negative . | Locus . | Genotype . | |
| VV | 19 (14.6) | 9 (9.7) | .27 | |
| VF | 76 (58.5) | 40 (43.0) | .0071 | .023 |
| FF | 35 (26.9) | 44 (47.3) | .0017 | |
| FcγRIIIA genotype . | Number of patients (%) . | Evidence for association, P values at . | ||
|---|---|---|---|---|
| HHV-8 positive . | HHV-8 negative . | Locus . | Genotype . | |
| VV | 19 (14.6) | 9 (9.7) | .27 | |
| VF | 76 (58.5) | 40 (43.0) | .0071 | .023 |
| FF | 35 (26.9) | 44 (47.3) | .0017 | |
Results of HHV-8 serologic status in combined population (including those with and without Kaposi's sarcoma) compared toFcγRIIIA 158 V/F genotype by 3 × 2 χ2 analysis with 2 degrees of freedom.